With cases accumulating in the COVID-19 pandemic, there is a need for safe, effective treatments. Certain existing medications may have value for treating COVID-19.
The COVID-19 virus has caused over 28 million cases in the US. Vaccination is underway, but new infections are still occurring regularly. Furthermore, some variants of the virus seem to spread more easily and quickly than other variants, which may lead to more cases of COVID-19. Some evidence suggests that there are safe, available medications developed for other purposes that may hold some value for also treating COVID-19. This nation-wide study will evaluate the effectiveness of such medications for treating COVID-19, aiming to enroll 15,000 patients across approximately 80 sites.
Would you like to help guide research related to COVID-19 treatment? The research team is looking to form a Stakeholder Advisory Committee to advise on the development of the study protocol. Goals include making sure that study procedures are convenient and acceptable to participants, and that the study enrolls a group of participants that reflects the diversity of the US population at risk for COVID-19.
Ages 21 and up; Live in MD, MI, NJ, OH,PA, VA, or WV; have experienced COVID-19 symptoms or acted as a caregiver for someone else who is/was ill from the COVID-19 virus.
Proposal in development
Want to ask a question or share an idea with this researcher? Go ahead and ask!
Your question may end up on this page! The researcher will review all questions and decide whether to post the answer publicly. Your question will not be attributed to you.
Do you or does someone you know have a story related to this study? Your story can help this researcher know what to study.
We'd love to hear it.
We're sorry. Team building for this study is now complete and it is no longer engaging additional people.
Wondering what it's like to be a patient partner in a clinical study? Here are some links to resources.
Copyright 2019 | PaTH Network
